| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 27.259 | 48.005 | 24.822 | 28.480 | 36.489 | 36.113 | 39.298 | 41.693 | 45.006 | 53.529 |
| Total Income - EUR | 28.166 | 48.005 | 25.225 | 142.191 | 47.025 | 46.450 | 51.427 | 47.777 | 51.320 | 53.530 |
| Total Expenses - EUR | 52.447 | 46.127 | 39.746 | 54.738 | 46.276 | 45.100 | 49.104 | 46.328 | 49.928 | 60.177 |
| Gross Profit/Loss - EUR | -24.281 | 1.878 | -14.521 | 87.453 | 750 | 1.350 | 2.323 | 1.449 | 1.391 | -6.648 |
| Net Profit/Loss - EUR | -25.126 | 1.398 | -14.773 | 86.031 | 279 | 886 | 1.809 | 971 | 878 | -7.183 |
| Employees | 3 | 3 | 3 | 5 | 3 | 3 | 3 | 2 | 2 | 2 |
Check the financial reports for the company - Roxvapin S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 16.257 | 17.294 | 17.881 | 7.882 | 8.880 | 8.325 | 4.494 | 4.844 | 3.510 | 2.217 |
| Current Assets | 38.437 | 28.938 | 3.568 | 8.682 | 8.895 | 12.138 | 17.238 | 14.078 | 13.289 | 17.030 |
| Inventories | 33.047 | 25.064 | 1.235 | 5.186 | 4.019 | 10.171 | 9.315 | 7.699 | 823 | 9.448 |
| Receivables | 3.017 | 1.569 | 1.823 | 2.961 | 4.103 | 1.230 | 5.849 | 3.395 | 3.930 | 5.423 |
| Cash | 2.373 | 2.305 | 510 | 535 | 773 | 737 | 2.074 | 2.984 | 8.536 | 2.159 |
| Shareholders Funds | -69.756 | -67.647 | -81.275 | 6.249 | 6.408 | 7.172 | 8.821 | 9.820 | 10.669 | 3.426 |
| Social Capital | 135 | 134 | 131 | 129 | 126 | 124 | 121 | 122 | 121 | 121 |
| Debts | 124.451 | 113.878 | 102.723 | 10.315 | 11.368 | 13.291 | 12.911 | 9.102 | 6.130 | 15.821 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4520 - 4520" | |||||||||
| CAEN Financial Year |
4520
|
|||||||||
Comments - Roxvapin S.r.l.